MA53617A - Composition pour inhiber l'activité de la trypsine, contenant, en tant que principe actif, une bactérie appartenant au genre paraprevotella - Google Patents

Composition pour inhiber l'activité de la trypsine, contenant, en tant que principe actif, une bactérie appartenant au genre paraprevotella

Info

Publication number
MA53617A
MA53617A MA053617A MA53617A MA53617A MA 53617 A MA53617 A MA 53617A MA 053617 A MA053617 A MA 053617A MA 53617 A MA53617 A MA 53617A MA 53617 A MA53617 A MA 53617A
Authority
MA
Morocco
Prior art keywords
trypsin
inhibiting
activity
composition
active principle
Prior art date
Application number
MA053617A
Other languages
English (en)
Inventor
Kenya Honda
Yusuke Kawashima
Youxian Li
Seiko Narushima
Osamu Ohara
Eiichiro Watanabe
Original Assignee
Riken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken filed Critical Riken
Publication of MA53617A publication Critical patent/MA53617A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MA053617A 2018-09-10 2019-09-10 Composition pour inhiber l'activité de la trypsine, contenant, en tant que principe actif, une bactérie appartenant au genre paraprevotella MA53617A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862728908P 2018-09-10 2018-09-10
US201962794145P 2019-01-18 2019-01-18

Publications (1)

Publication Number Publication Date
MA53617A true MA53617A (fr) 2021-07-21

Family

ID=69777875

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053617A MA53617A (fr) 2018-09-10 2019-09-10 Composition pour inhiber l'activité de la trypsine, contenant, en tant que principe actif, une bactérie appartenant au genre paraprevotella

Country Status (7)

Country Link
US (1) US20220047647A1 (fr)
EP (1) EP3851517A4 (fr)
JP (2) JP7399400B2 (fr)
CN (1) CN113015790A (fr)
CA (1) CA3112501A1 (fr)
MA (1) MA53617A (fr)
WO (1) WO2020054728A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022158434A1 (fr) * 2021-01-19 2022-07-28 国立研究開発法人理化学研究所 Composition pour la décomposition de la trypsine ou de tmprss2
US12011467B2 (en) * 2021-05-18 2024-06-18 J. Craig Venter Institute, Inc. Bacterial formulation
WO2023225573A2 (fr) * 2022-05-17 2023-11-23 Purdue Research Foundation Dosages, kits et procédés de détection de contamination
CN116790402B (zh) * 2023-01-14 2024-05-14 西北农林科技大学 一株具有抗炎特性的单形拟杆菌菌株、培养方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
AU2008317000B2 (en) * 2007-10-26 2014-10-23 Brenda E. Moore Probiotic compositions and methods for inducing and supporting weight loss
CN104955466A (zh) 2012-11-23 2015-09-30 赛里斯治疗公司 协同细菌组合物和其制造方法和用途
WO2015003001A1 (fr) * 2013-07-01 2015-01-08 The Washington University Procédés pour identifier des compléments qui augmentent la colonisation intestinale par une espèce bactérienne isolée, et compositions dérivées
CA2926466C (fr) * 2013-10-03 2021-11-16 Frederic Bushman Compositions comprenant un microbiome defini et procedes d'utilisation de ces compositions
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
US20180110800A1 (en) * 2016-10-24 2018-04-26 LifeBridge Health, Inc. Targeted synbiotic therapy for dysbiosis-related intestinal and extra-intestinal disorders
CN110191946A (zh) * 2016-12-23 2019-08-30 学校法人庆应义塾 诱导cd8+t细胞的组合物及方法

Also Published As

Publication number Publication date
EP3851517A4 (fr) 2022-06-15
JP2024026163A (ja) 2024-02-28
CA3112501A1 (fr) 2020-03-19
CN113015790A (zh) 2021-06-22
EP3851517A1 (fr) 2021-07-21
WO2020054728A1 (fr) 2020-03-19
JPWO2020054728A1 (ja) 2021-09-09
JP7399400B2 (ja) 2023-12-18
US20220047647A1 (en) 2022-02-17

Similar Documents

Publication Publication Date Title
MA53617A (fr) Composition pour inhiber l'activité de la trypsine, contenant, en tant que principe actif, une bactérie appartenant au genre paraprevotella
MA46452B1 (fr) Composés de benzo[b]thiophéne en tant qu'agonistes de sting
MA42678B1 (fr) Nouveaux analogues nucléosidiques substitués à cycle aromatique bicyclique 6-6 pour une utilisation en tant qu'inhibiteurs de prmt5
UA116809C2 (uk) Застосування агрохімічних сумішей для збільшення життєздатності рослини
PE20180021A1 (es) Derivados de sobetiroma
DOP2006000170A (es) Nuevos derivados de espirocromanona
CR20120190A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
MA37519A1 (fr) Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
AR090456A1 (es) Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos
MA37539A1 (fr) Dérivé de sulfure d'alkylphényle et agent de lutte contre les organismes nuisibles
EA201070988A1 (ru) Противовирусные терапевтические средства
MA35172B1 (fr) Melanges pestticides contenant des derives d'isoxazoline
MA40281B1 (fr) Composés de pyrazole et leur utilisation en tant qu' agents de blocage des canaux calciques de type t
EA200800777A1 (ru) Применение сложных эфиров молочной кислоты для улучшения действия пестицидов
EA201992542A1 (ru) Фармацевтическая композиция для местного применения, содержащая, по меньшей мере, амитриптилин, для лечения периферической нейропатической боли
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
MA38556A1 (fr) Inhibiteurs de bace1
FR2973700B1 (fr) Nouvel actif derivant d'une bacterie appartenant au genre vitreoscilla sp. utile pour prevenir et/ou traiter les etats pelliculaires du cuir chevelu
MA33618B1 (fr) Agent thérapeutique destiné aux troubles de l'humeur
EA201992509A1 (ru) Гетероарилфениламинохинолины и аналоги
EA201001586A1 (ru) Соединения и композиции в качестве ингибиторов itpkb
NZ746906A (en) Oxaborole esters and uses thereof
AR089409A1 (es) Agente de control de enfermedades de las plantas
CO2019004547A2 (es) Derivado de urea
CO2018007788A2 (es) Compuesto novedoso de ácido bisfosfónico